It is doubtless that within the High Dividend Opportunities' Model Portfolio, we do have some drama babies. Today, I want to ...

Ares Capital's Q2 showed mixed results, with declining net investment income but stable fundamentals. Read why I maintain a ...

Medicare is expanding its drug price negotiation program to include 15 more medications, including popular drugs like Ozempic ...